|
| 38001050 | Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines. | Eur Heart J Acute Cardiovasc Care | 2024 |
| 35108618 | Physiologic guidance for percutaneous coronary intervention: State of the evidence. | Trends Cardiovasc Med | 2023 |
| 37610768 | Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial. | JAMA Cardiol | 2023 |
| 37610731 | Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial. | JAMA Cardiol | 2023 |
| 37878287 | Realigning Priorities in the Evaluation and Management of Patients With Heart Failure. | JAMA Cardiol | 2023 |
| 37821170 | Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease. | J Am Coll Cardiol | 2023 |
| 37639276 | Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. | JAMA Cardiol | 2023 |
| 37115135 | Guideline-Directed Medical Therapy Tolerability in Patients With Heart Failure and Mitral Regurgitation: The COAPT Trial. | JACC Heart Fail | 2023 |
| 37115132 | No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies. | JACC Heart Fail | 2023 |
| 36582184 | Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments. | Eur Heart J | 2023 |
| 36828202 | Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial. | Am Heart J | 2023 |
| 34843844 | Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function. | Am J Kidney Dis | 2022 |
| 35680197 | Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk Factors. | JACC Cardiovasc Interv | 2022 |
| 35472391 | Rates of In-Hospital Decongestion and Association with Mortality and Cardiovascular Outcomes Among Patients Admitted for Acute Heart Failure. | Am J Med | 2022 |
| 36250238 | Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum. | Eur J Heart Fail | 2022 |
| 36075613 | Straining for Surrogacy. | JACC Cardiovasc Imaging | 2022 |
| 35969651 | Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook. | Circulation | 2022 |
| 36328648 | Does an Ischemic "STICH in Time Save Nine" for Patients Newly Diagnosed With Heart Failure? | JACC Heart Fail | 2022 |
| 35926903 | The PROMISE Minimal Risk Score Improves Risk Classification of Symptomatic Patients With Suspected CAD. | JACC Cardiovasc Imaging | 2022 |
| 36058253 | Primary left ventricular unloading with delayed reperfusion in patients with anterior ST-elevation myocardial infarction: Rationale and design of the STEMI-DTU randomized pivotal trial. | Am Heart J | 2022 |
| 33907929 | Is heart failure with preserved ejection fraction a 'dementia' of the heart? | Heart Fail Rev | 2022 |
| 33610723 | Editorial commentary: Advances in cardiac imaging: Mind the (Translational) gap. | Trends Cardiovasc Med | 2022 |
| 34953768 | The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial. | Am Heart J | 2022 |
| 33440999 | Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction. | Circ Cardiovasc Interv | 2021 |
| 33521873 | Assessing myocardial perfusion in suspected coronary artery disease: rationale and design of the second phase 3, open-label multi-center study of flurpiridaz (F-18) injection for positron emission tomography (PET) imaging. | J Nucl Cardiol | 2021 |
| 33766254 | Discordance of High-Sensitivity Troponin Assays in Patients With Suspected Acute Coronary Syndromes. | J Am Coll Cardiol | 2021 |
| 34379929 | Imaging in Coronary Artery Disease Risk Stratification. | N Engl J Med | 2021 |
| 34077743 | Estimating the real-world performance of the PROMISE minimal-risk tool. | Am Heart J | 2021 |
| 34042956 | Return to Play for Athletes After COVID-19 Infection: The Fog Begins to Clear. | JAMA Cardiol | 2021 |
| 34317678 | Pulmonary Tumor Thrombotic Microangiopathy as a Cause of Pulmonary Hypertension. | JACC Case Rep | 2021 |
| 33188886 | Dual Vasopressin Receptor Antagonism to Improve Congestion in Patients With Acute Heart Failure: Design of the AVANTI Trial. | J Card Fail | 2021 |
| 33104177 | Return to Play for Athletes After Coronavirus Disease 2019 Infection-Making High-Stakes Recommendations as Data Evolve. | JAMA Cardiol | 2021 |
| 31601728 | Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia. | Heart | 2020 |
| 31919727 | Chronic Conditions in Advanced Cardiac Disease: A Cluster Analysis of Transcatheter Aortic Valve Replacement (TAVR)-Treated Patients. | J Gen Intern Med | 2020 |
| 32105984 | Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF). | Am Heart J | 2020 |
| 32068002 | Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial. | J Card Fail | 2020 |
| 33315111 | Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain. | JAMA Netw Open | 2020 |
| 33079154 | Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial. | JAMA | 2020 |
| 33102958 | Association of Volume Overload With Kidney Function Outcomes Among Patients With Heart Failure With Reduced Ejection Fraction. | Kidney Int Rep | 2020 |
| 32905421 | Can Clinical Predictive Models Identify Patients Who Should Not Receive TAVR? A Systematic Review. | Struct Heart | 2020 |
| 32675839 | TESTING OUR TESTS: THE EVOLUTION OF EVIDENCE FOR CARDIAC IMAGING. | Trans Am Clin Climatol Assoc | 2020 |
| 32703509 | Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease. | J Am Coll Cardiol | 2020 |
| 32415147 | Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment. | Nat Rev Cardiol | 2020 |
| 32299585 | Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI. | J Am Coll Cardiol | 2020 |
| 32268807 | Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. | Circ Cardiovasc Imaging | 2020 |
| 32295407 | Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure: DRI<sub>2</sub>P<sub>2</sub>S. | Circ Heart Fail | 2020 |
| 32535124 | Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure. | JACC Heart Fail | 2020 |
| 30586728 | Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction. | Circulation | 2019 |
| 31722536 | Impact of Autonomic Regulation Therapy in Patients with Heart Failure: ANTHEM-HFrEF Pivotal Study Design. | Circ Heart Fail | 2019 |
| 32097923 | Hypervolemic Hyponatremia in Heart Failure. | Front Horm Res | 2019 |